[6-K] Haleon plc American Current Report (Foreign Issuer)

Rhea-AI Filing Summary

Haleon plc reports the purchase and cancellation of 2,191,437 ordinary shares of
each as part of the second tranche of its buyback programme announced 31 July 2025.

Trades executed on 28 August 2025 totalled 2,191,437 shares at prices reported on the London Stock Exchange/CBOE (UK)/CXE with an average indicative price shown in the announcement. After settlement, registered share capital is 8,961,283,874 ordinary shares, with 3,880,205 held in treasury, leaving 8,957,403,669 ordinary shares carrying voting rights. The company provides a link to a full breakdown of individual trades and notes the announcement is not an offer for securities. More details are available on the company website.

Positive

• Buyback executed: Company completed a tranche purchase of 2,191,437 ordinary shares for cancellation
• Updated capital clarity: Filing provides post-transaction registered share capital and exact voting-share count (8,957,403,669) useful for disclosure thresholds
• Regulatory transparency: Full trade breakdown link provided and Market Abuse Regulation reference

Negative

• No cash amount disclosed: Filing does not state total cash spent on the buyback or remaining programme size
• No financial impact quantified: Announcement does not provide expected effects on EPS, leverage, or capital allocation

Insights

Securities Analyst

TL;DR The announced buyback is a routine capital return reducing shares outstanding modestly without detailed financial impacts disclosed.

The filing confirms a specific buyback tranche: 2,191,437 ordinary shares were purchased and cancelled, and post-transaction share counts are provided. This reduces the number of shares with voting rights to 8,957,403,669, which is material for ownership disclosure thresholds. The company links to a full trade breakdown but does not disclose aggregate cash spent or the buyback programme's remaining size in this filing. Impact on EPS or capital structure cannot be quantified from this notice alone.

Corporate Governance Expert

TL;DR The filing documents a standard share cancellation under an existing programme and updates voting share counts for regulatory disclosure.

The announcement fulfils regulatory transparency by listing the number of shares cancelled, resulting registered capital, treasury holdings, and voting-share count for FCA notification purposes. It references compliance with Market Abuse Regulation requirements by providing a trade breakdown link. No governance changes or executive actions are disclosed; the item is procedural and regulatory in nature.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2025

Commission File Number: 001-41411

Haleon plc

(Translation of registrant’s name into English)

Building 5, First Floor, The Heights,

Weybridge, Surrey, KT13 0NY

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

EXHIBIT INDEX

Exhibit Number	Description
99.1	29 August 2025 - Transaction in Own Shares

99.1

Haleon plc: Transaction in own shares

29 August 2025: Haleon plc (the "Company" or "Haleon") today announces the purchase of 2,191,437 ordinary shares of £0.01 each in the Company (the "Shares") for cancellation under the second tranche of its share buyback programme announced on 31 July 2025.

	London Stock Exchange	CBOE (UK)/BXE	CBOE (UK)/CXE
Date of purchase:	28 August 2025	28 August 2025	28 August 2025
Number of Shares purchased:	2,191,437	-	-
Highest price paid per Share (p):	364.0000	-	-
Lowest price paid per Share (p):	359.9000	-	-
Volume weighted average price paid per Share (p):	361.6800	-	-

Following the settlement of the above, the Company's registered share capital is 8,961,283,874 ordinary shares of £0.01 each, of which 3,880,205 are held as treasury shares. Therefore, the number of ordinary shares with voting rights is 8,957,403,669 and this figure may be used by shareholders to determine if they are required to notify their interest, or a change to their interest, in Haleon under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual trades is available at the link below:

http://www.rns-pdf.londonstockexchange.com/rns/1291X_1-2025-8-28.pdf

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This announcement and individual trade breakdown will also be available on the Company's website at: www.haleon.com/investors.

Enquiries
Investors		Media
Jo Russell	+44 7787 392441	Zoë Bird	+44 7736 746167
Rakesh Patel	+44 7552 484646	Victoria Durman	+44 7894 505730
Email: investor-relations@haleon.com		Email: corporate.media@haleon.com

About Haleon

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.

For more information, please visit www.haleon.com. 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		HALEON PLC (Registrant)
Date: August 29, 2025	By:	/s/ Amanda Mellor
		Name:	Amanda Mellor
		Title:	Company Secretary

FAQ

How many shares did Haleon plc (HLN) purchase and cancel on 28 August 2025?

The company purchased and cancelled 2,191,437 ordinary shares.

What is Haleon's number of ordinary shares with voting rights after this transaction?

After settlement the number of ordinary shares with voting rights is 8,957,403,669.

How many treasury shares does Haleon hold following the buyback?

Haleon holds 3,880,205 treasury shares as stated in the filing.

Where can I find a full breakdown of the individual trades for this buyback?

The filing provides a link to the trade breakdown: http://www.rns-pdf.londonstockexchange.com/rns/1291X_1-2025-8-28.pdf and it will be available on www.haleon.com/investors.

Does this announcement constitute an offer for securities?

No. The announcement explicitly states it does not constitute or form part of an offer or solicitation for securities in any jurisdiction.